Abstract:Significance statement: Genome-wide association studies have identified nearly 20 IgA nephropathy susceptibility loci. However, most nonsynonymous coding variants, particularly ones that occur rarely or at a low frequency, have not been well investigated. The authors performed a chip-based association study of IgA nephropathy in 8529 patients with the disorder and 23,224 controls. They identified a rare variant in the gene encoding vascular endothelial growth factor A (VEGFA) that was significantly associated with a two-fold increased risk of IgA nephropathy, which was further confirmed by sequencing analysis. They also identified a novel common variant in PKD1L3 that was significantly associated with lower haptoglobin protein levels. This study, which was well-powered to detect low-frequency variants with moderate to large effect sizes, helps expand our understanding of the genetic basis of IgA nephropathy susceptibility. Background: Genome-wide association studies have identified nearly 20 susceptibility loci for IgA nephropathy. However, most nonsynonymous coding variants, particularly those occurring rarely or at a low frequency, have not been well investigated. Methods: We performed a three-stage exome chip-based association study of coding variants in 8529 patients with IgA nephropathy and 23,224 controls, all of Han Chinese ancestry. Sequencing analysis was conducted to investigate rare coding variants that were not covered by the exome chip. We used molecular dynamic simulation to characterize the effects of mutations of VEGFA on the protein's structure and function. We also explored the relationship between the identified variants and the risk of disease progression. Results: We discovered a novel rare nonsynonymous risk variant in VEGFA (odds ratio, 1.97; 95% confidence interval [95% CI], 1.61 to 2.41; P = 3.61×10 -11 ). Further sequencing of VEGFA revealed twice as many carriers of other rare variants in 2148 cases compared with 2732 controls. We also identified a common nonsynonymous risk variant in PKD1L3 (odds ratio, 1.16; 95% CI, 1.11 to 1.21; P = 1.43×10 -11 ), which was associated with lower haptoglobin protein levels. The rare VEGFA mutation could cause a conformational change and increase the binding affinity of VEGFA to its receptors. Furthermore, this variant was associated with the increased risk of kidney disease progression in IgA nephropathy (hazard ratio, 2.99; 95% CI, 1.09 to 8.21; P = 0.03). Conclusions: Our study identified two novel risk variants for IgA nephropathy in VEGFA and PKD1L3 and helps expand our understanding of the genetic basis of IgA nephropathy susceptibility.

Genetic Studies of IgA Nephropathy: Present, Chances and Challenges

Genetic Studies of IgA Nephropathy: What Have We Learned from Genome-Wide Association Studies.

Genetic studies of IgA nephropathy: past, present, and future

Research Progress of IgA Nephropathy Genetics

Genetics of IgA nephrology: risks, mechanisms, and therapeutic targets

An Update on the Genetics of IgA Nephropathy

[Advances in Molecular Genetics Research of IgA Nephropathy].

Pathogenesis of IgA nephropathy:advances in molecular genetics research

[Current status and prospects of genetic research on IgA nephropathy]

The Genetics of IgA Nephropathy: an Overview from China

What Genetics Tells Us About the Pathogenesis of IgA Nephropathy: The Role of Immune Factors and Infection.

Functional networks of aging markers in the glomeruli of IgA nephropathy: a new therapeutic opportunity.

Exome Chip Analyses and Genetic Risk for IgA Nephropathy among Han Chinese

IgA Nephropathy: Current Understanding and Perspectives on Pathogenesis and Targeted Treatment

New Insights into the Pathogenesis of IgA Nephropathy

Geographic Differences in Genetic Susceptibility to IgA Nephropathy: GWAS Replication Study and Geospatial Risk Analysis

Genome-Wide Meta-Analysis Identifies Three Novel Susceptibility Loci and Reveals Ethnic Heterogeneity of Genetic Susceptibility for IgA Nephropathy

Identification of new susceptibility loci for IgA nephropathy in Han Chinese

Gene prediction of the causal relationship between immune cells and IgA nephropathy: A bidirectional Mendelian randomization study

Genome-Wide Association Analysis of Protein-Coding Variants in IgA Nephropathy

The pathophysiology of IgA nephropathy